Jonathan Richard, Ph.D. - Publications

Affiliations: 
2013 Microbiology and Immunology Université de Montréal, Montréal, Canada 
Area:
Virology Biology, Immunology, Microbiology Biology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Parsons MS, Richard J, Lee WS, Vanderven H, Grant MD, Finzi A, Kent SJ. NKG2D acts as a co-receptor for natural killer cell-mediated anti-HIV-1 antibody-dependent cellular cytotoxicity. Aids Research and Human Retroviruses. PMID 27487965 DOI: 10.1089/AID.2016.0099  0.76
2016 Richard J, Veillette M, Ding S, Zoubchenok D, Alsahafi N, Coutu M, Brassard N, Park J, Courter JR, Melillo B, Smith AB, Shaw GM, Hahn BH, Sodroski J, Kaufmann DE, et al. Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity. Ebiomedicine. 3: 122-34. PMID 26870823 DOI: 10.1016/j.ebiom.2015.12.004  0.76
2016 Veillette M, Richard J, Pazgier M, Lewis GK, Parsons MS, Finzi A. Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses. Current Hiv Research. 14: 9-23. PMID 26310828  0.76
2015 Alsahafi N, Ding S, Richard J, Markle T, Brassard N, Walker B, Lewis GK, Kaufmann DE, Brockman MA, Finzi A. Nef proteins from HIV-1 elite controllers are inefficient at preventing ADCC. Journal of Virology. PMID 26719277 DOI: 10.1128/JVI.02973-15  0.76
2015 Lee WS, Richard J, Lichtfuss M, Smith AB, Park J, Courter JR, Melillo BN, Sodroski JG, Kaufmann DE, Finzi A, Parsons MS, Kent SJ. Antibody-dependent cellular cytotoxicity against reactivated HIV-1-infected cells. Journal of Virology. PMID 26656700 DOI: 10.1128/JVI.02717-15  0.76
2015 Murray MK, Teran VA, Chapleau JP, Wang B, Kim SH, LaBranche CC, Richard J, Montefiori DC, Finzi A, Yuan W. Soluble Envelope Glycoprotein Trimers from a CD4-Independent HIV-1 Elicit Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Guinea Pigs. Journal of Virology. 89: 10707-11. PMID 26246571 DOI: 10.1128/JVI.01642-15  0.76
2015 Richard J, Veillette M, Brassard N, Iyer SS, Roger M, Martin L, Pazgier M, Schön A, Freire E, Routy JP, Smith AB, Park J, Jones DM, Courter JR, Melillo BN, et al. CD4 mimetics sensitize HIV-1-infected cells to ADCC. Proceedings of the National Academy of Sciences of the United States of America. 112: E2687-94. PMID 25941367 DOI: 10.1073/pnas.1506755112  0.76
2015 Veillette M, Coutu M, Richard J, Batraville LA, Dagher O, Bernard N, Tremblay C, Kaufmann DE, Roger M, Finzi A. The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. Journal of Virology. 89: 545-51. PMID 25339767 DOI: 10.1128/JVI.02868-14  0.76
2015 Gooneratne SL, Richard J, Lee WS, Finzi A, Kent SJ, Parsons MS. Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells. Journal of Virology. 89: 97-109. PMID 25320293 DOI: 10.1128/JVI.02461-14  0.76
2014 Batraville LA, Richard J, Veillette M, Labbé AC, Alary M, Guédou F, Kaufmann DE, Poudrier J, Finzi A, Roger M. Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers. Aids Research and Human Retroviruses. 30: 1145-9. PMID 25354025 DOI: 10.1089/aid.2014.0163  0.76
2014 Veillette M, Coutu M, Richard J, Batraville LA, Désormeaux A, Roger M, Finzi A. Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay. Journal of Visualized Experiments : Jove. 51995. PMID 25286159 DOI: 10.3791/51995  0.76
2014 Herschhorn A, Gu C, Espy N, Richard J, Finzi A, Sodroski JG. A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry. Nature Chemical Biology. 10: 845-52. PMID 25174000 DOI: 10.1038/nchembio.1623  0.76
2014 Richard J, Veillette M, Batraville LA, Coutu M, Chapleau JP, Bonsignori M, Bernard N, Tremblay C, Roger M, Kaufmann DE, Finzi A. Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses. Journal of Virological Methods. 208: 107-14. PMID 25125129 DOI: 10.1016/j.jviromet.2014.08.003  0.76
2013 Richard J, Pham TN, Ishizaka Y, Cohen EA. Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes. Virology. 443: 248-56. PMID 23726848 DOI: 10.1016/j.virol.2013.04.037  0.76
2011 Pham TN, Richard J, Gerard FC, Power C, Cohen ÉA. Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates. Journal of Virology. 85: 12254-61. PMID 21957298 DOI: 10.1128/JVI.05835-11  0.76
2010 Richard J, Cohen ÉA. HIV-1 Vpu disarms natural killer cells. Cell Host & Microbe. 8: 389-91. PMID 21075348 DOI: 10.1016/j.chom.2010.11.001  0.76
2010 Belzile JP, Richard J, Rougeau N, Xiao Y, Cohen EA. HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest. Journal of Virology. 84: 3320-30. PMID 20089662 DOI: 10.1128/JVI.02590-09  0.76
2010 Richard J, Sindhu S, Pham TN, Belzile JP, Cohen EA. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood. 115: 1354-63. PMID 20008788 DOI: 10.1182/blood-2009-08-237370  0.76
2010 Yang YX, Guen V, Richard J, Cohen EA, Berthoux L. Cell context-dependent involvement of ATR in early stages of retroviral replication. Virology. 396: 272-9. PMID 19913868 DOI: 10.1016/j.virol.2009.10.032  0.76
2008 Xiao Y, Chen G, Richard J, Rougeau N, Li H, Seidah NG, Cohen EA. Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases. Virology. 372: 384-97. PMID 18061232 DOI: 10.1016/j.virol.2007.10.036  0.76
Show low-probability matches.